1. Canada Stocks

  2. •

    Consumer Defensive

  3. •

    Packaged Foods
BioNeutra Global Corporation

BioNeutra Global Corporation

BGACF
BioNeutra Global CorporationUS flagOther OTC
0.01
USD
- -
- -
260,113.00Market Cap
2012 Y
2013 Y
2014 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
- -
- -
4.21
- -
0.36
0.57
0.7
0.82
0.81
0.52
0.33
0.29
0.25
0.24
Basic EPS, GAAP
- -
- -
0.38
- -
- -
0.02
-0.03
0.07
-0.27
-0.08
-0.06
-0.06
-0.05
-0.01
Free Cash Flow per Basic Share
-0.01
- -
0.53
- -
-0.21
-0.03
0.01
0.05
0.01
0.03
-0.01
0.01
0.01
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.13
-0.13
0.6
- -
0.11
0.13
0.26
0.33
0.07
-0.01
-0.07
-0.14
-0.18
-0.23
Tangible Book Value per Share
0.02
0.02
0.69
- -
0.24
0.27
0.25
0.35
0.08
- -
-0.03
-0.09
-0.14
-0.19
Basic Weighted Avg Shares
12
12
2
- -
45
46
46
46
46
46
46
46
46
45
Sales/Revenue/Turnover
- -
- -
8
- -
16
26
32
38
38
24
15
13
11
11
Operating Margin (%)
- -
- -
21.49
- -
3.68
10.46
-0.07
6.36
-26.08
-12.55
-15.29
-18.42
-12.64
-3.16
Depreciation Expense
- -
- -
- -
- -
1
1
1
2
2
2
1
1
1
- -
Net Income, GAAP
- -
- -
1
- -
- -
1
-1
3
-12
-4
-3
-3
-2
-1
Effective Tax Rate (%)
- -
- -
40.02
- -
80.35
49.92
- -
13.14
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
8.96
- -
1.12
4.15
-3.61
8.23
-33.01
-15.37
-18.37
-21.82
-18.52
-5.62
Working Capital
- -
- -
- -
4
7
8
5
9
-2
-4
-5
-7
-8
-10
LT Debt
- -
- -
- -
- -
9
9
8
8
7
6
6
7
7
7
Total Equity
- -
- -
2
11
15
16
14
18
5
1
-1
-4
-6
-8
Return on Invested Capital (%)
- -
- -
80.12
- -
0.66
5.39
- -
8.12
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-304.13
- -
2.24
8.78
- -
15.48
- -
- -
- -
- -
- -
779.19
Return on Common Equity (%)
- -
- -
- -
- -
3.71
19.72
-12.78
22.64
-135.83
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'24
Sep'24
ST Debt
1
1
1
LT Borrowings
7
7
7
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
46
46
46
Market Capitalization
4
4
4

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'24
Sep'24
Total Current Assets
7
6
5
Cash, Cash Equivalents & STI
- -
- -
1
Accounts Receivable, Net
1
1
1
Inventories
5
4
3
Total Current Liabilities
16
15
15
Payables & Accruals
15
15
14
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
43.88%
-15.65%
64.92%
Free Cash Flow
- -
-55.18%
4.66%
Net Income, GAAP
- -
-123.9%
-27.86%
Sales/Revenue/Turnover
- -
-20.05%
-15%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
4
4
3
3
13
2023
3
3
3
3
11
2024
2
3
3
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
-0.01
-0.03
- -
-0.06
2023
-0.02
-0.03
-0.03
- -
-0.05
2024
-0.02
-0.02
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Jianhua Zhu
Full Time Employees
51
Sector
Consumer Defensive
Industry
Packaged Foods
Address
9608 - 25 Avenue NW Vancouver BC Canada T6N 1J4
IPO Date
Dec 2, 2021
Website
bioneutra.ca
Similar Companies
UMeWorld Inc. (UMEW)
Greencore Group plc (GNC.L)
PT Panca Mitra Multiperdana Tbk (PMMP.JK)
Dhunseri Ventures Limited (DVL.NS)
Charoen Pokphand Enterprise (Taiwan) Co., Ltd. (1215.TW)
Ter Beke N.V. (TERB.BR)
Business
BioNeutra Global Corporation engages in the research, development, production, and commercialization of ingredients for nutraceutical, functional, and mainstream foods and beverages, with a focus on oligosaccharides including its flagship VitaFiber IMO offered in powder and syrup forms; low-calorie nutritive sweeteners with prebiotic function and dietary fiber properties; VitaFiber IMO enhanced with FDA-approved dietary fiber; less sweet high-fiber variants of VitaFiber IMO; and resistant dextrin for fiber enrichment in various foods. The company operates a manufacturing facility in Edmonton, Alberta, Canada, serving customers worldwide with primary revenue from the United States and distribution across North America, Europe, Australia, and other regions. Founded in 1996 by Jianhua Zhu, who serves as president and CEO, BioNeutra Global maintains its headquarters in Edmonton and operates through subsidiaries including BioNeutra North America Inc. In May 2024, its wholly owned subsidiary BioNeutra North America Inc. signed a Master Partnership Agreement with Protein Industries Canada, Roquette Canada Ltd., Prairie Fava Ltd., and Plant Up Inc. to develop new pea starch-derived products, securing $5.7 million in project funding with $2.4 million eligible repayable contribution, while exploring construction of a large-scale production facility in Canada to expand beyond isomaltooligosaccharides into multiple product families supporting plant protein industry stability.